Luca Pani, MD

Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Miami, Miami, Florida; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy

  • 6Articles
  • 28.6KReads
  • 2016–2025Active
  • 42Collaborators
  • 39Citations

About

Luca Pani, MD, is affiliated with the Department of Psychiatry and Behavioral Sciences at the University of Miami and the Department of Biomedical, Metabolic and Neural Sciences at the University of Modena and Reggio Emilia. Pani has authored six articles between 2016 and 2025 focusing on major depressive disorder (MDD), particularly investigating the efficacy, safety, and therapeutic response to esmethadone (REL-1017) in patients with MDD, including those with antidepressant tachyphylaxis and inadequate response to standard treatments. Additional research includes adherence to selective serotonin and serotonin-norepinephrine reuptake inhibitor prescriptions in older adults. Frequent collaborators include Andrea Mattarei, Clotilde Guidetti, Franco Folli, Marco Pappagallo, and Maurizio Fava.

Publications

JCP
Esmethadone (REL-1017) in Patients with Major Depressive Disorder and Antidepressant Tachyphylaxis
JCP
Long-Term Safety and Efficacy of Esmethadone in MDD
JCP
Esmethadone in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants
JCP
Effect of Time From Onset of MDD on Response to Esmethadone
PCC
REL-1017 Effects on Cognition in MDD
JCP

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.